Search

Robert A Gulakowski

from Johnstown, PA
Age ~86
Get Report
Also known as:
Robert J Gulakowski, Rob A Gulakowski, Bob A Gulakowski, Roman Gulakowski
Phone and address:
213 Clermont St, Johnstown, PA 15904
(814) 266-5080
Related to:
Kimberley GulakowskiBarbara A Gulakowski, 81G RomanJoseph Ference, 89Catherine Gulakowski, 81Andrea B Gulakowski, 57Margaret J Ference, 87Emily T Gulakowski, 29Lisa F Wroblewski, 62Dorene A Gulakowski, 71Terry MarkmanJulius MarkmanJoseph A Ference, 63Roman Gulakowski, 50Melanie J Gulakowski, 34Roman GulakowskiMaryanne Gulakowski, 70
Connected to:
George M Gulalo, 77James A Gulalo, 75Abdul S Gulam, 42Hasan Gulam, 73Riaz S Gulam, 58Sayeeda G Gulam, 55Salomon A Gulamov, 57Larry F Gulan, 74Janet S Gular, 59Robert E Gulardo, 94

Robert Gulakowski Phones & Addresses

  • 213 Clermont St, Johnstown, PA 15904 (814) 266-5080
  • 11413 Scottsbury Ter, Germantown, MD 20876 (301) 972-3396
  • 18001 Cloppers Mill Ter, Germantown, MD 20874 (301) 528-0681
  • 18001 Cloppers Mill Ter #K, Germantown, MD 20874 (301) 528-0681
  • Central City, PA
  • 11118 Troy Rd, Rockville, MD 20852 (301) 770-0862
  • 5820 Inman Park Cir, Rockville, MD 20852 (301) 231-5660
  • Frederick, MD

Publications

Us Patents

Michellamine Antiviral Agents, Compositions, And Treatment Methods

View page
US Patent:
54552516, Oct 3, 1995
Filed:
Apr 19, 1993
Appl. No.:
8/049824
Inventors:
Michael R. Boyd - Ijamsville MD
John H. Cardellina - Walkersville MD
Kirk P. Manfredi - Frederick MD
John W. Blunt - Christchurch, NZ
Lewis K. Pannell - Silver Spring MD
James B. McMahon - Frederick MD
Robert J. Gulakowski - Frederick MD
Gordon M. Cragg - Bethesda MD
Gerhard Bringmann - Wurzburg, DE
Duncan Thomas - Corvallis OR
Johnson Jato - Yaounde, CM
Assignee:
The United States of America as represented by the Secretary of the
Department of Health and Human Services - Washington DC
International Classification:
A61K 3147
C07D40110
US Classification:
514308
Abstract:
The present invention provides new antiviral compounds, i. e. , michellamines and derivatives and pharmacologically acceptable salts thereof, methods for isolating such antiviral compounds from a plant species of the genus Ancistrocladus, antiviral compositions containing such antiviral compounds, and methods of using such antiviral compounds for treating patients with viral infections. The antiviral compounds of the present invention inhibit the reproduction and cytopathicity of human acquired immunodeficiency viruses.

Process Of Preparing Michellamine Compounds

View page
US Patent:
56544324, Aug 5, 1997
Filed:
Jun 1, 1995
Appl. No.:
8/457677
Inventors:
Michael R. Boyd - Ijamsville MD
John H. Cardellina - Walkersville MD
Kirk P. Manfredi - Frederick MD
John W. Blunt - Christchurch, NZ
Lewis K. Pannell - Silver Spring MD
James B. McMahon - Frederick MD
Robert J. Gulakowski - Frederick MD
Gordon M. Cragg - Bethesda MD
Gerhard Bringmann - Wurzburg, DE
Duncan Thomas - Corvallis OR
Johnson Jato - Yaounde, ZA
Assignee:
The United States of America, as represented by the Department of Health
and Human Services - Washington DC
International Classification:
C07D40104
US Classification:
546140
Abstract:
The present invention provides new antiviral compounds, i. e. , michellamines and derivatives and pharmacologically acceptable salts thereof, methods for isolating such antiviral compounds from a plant species of the genus Ancistrocladus, antiviral compositions containing such antiviral compounds, and methods of using such antiviral compounds for treating patients with viral infections. The antiviral compounds of the present invention inhibit the reproduction and cytopathicity of human acquired immunodeficiency viruses.
Control profile
Robert A Gulakowski from Johnstown, PA, age ~86 Get Report